Literature DB >> 17275556

Is routine inclusion of level IV necessary in neck dissection for clinically N0 supraglottic carcinoma?

Sedat Cağli1, Imdat Yüce, Ercihan Güney.   

Abstract

OBJECTIVE: Elective level II to IV dissection has become a common practice for patients with N0 neck and supraglottic laryngeal carcinoma. Several authors have questioned the necessity of dissecting level IV and the possible risk of associated morbidities such as chyle leak and phrenic nerve injury. STUDY DESIGN AND
SETTING: We reviewed 58 patients who underwent elective functional and lateral neck dissection for supraglottic carcinoma. Node levels were delineated just after the removal of the specimens. The patients were followed at least 3 years postoperatively or until the time of death; recurrence rates and levels were evaluated.
RESULTS: Occult lymph node metastases were determined in 14 cases. Level II was the most involved zone (7 patients). Isolated level IV lymph node metastasis was not established.
CONCLUSION: We think that routine level IV dissection is not necessary in the management of clinically and radiologically N0 necks in patients with supraglottic laryngeal carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17275556     DOI: 10.1016/j.otohns.2006.08.009

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

Review 1.  Superselective neck dissection: rationale, indications, and results.

Authors:  Carlos Suárez; Juan P Rodrigo; K Thomas Robbins; Vinidh Paleri; Carl E Silver; Alessandra Rinaldo; Jesus E Medina; Marc Hamoir; Alvaro Sanabria; Vanni Mondin; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-16       Impact factor: 2.503

2.  Occult metastases from T1-T2 supraglottic carcinoma: role of primary tumor localization.

Authors:  Imdat Yüce; Sedat Cağli; Ali Bayram; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-05       Impact factor: 2.503

3.  Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer.

Authors:  A Teymoortash; J A Werner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.